Earnings Season Arrives Into a Geopolitical Minefield — Here's What Retail Is Betting On

Welcome to Q2 earnings season, where the backdrop is US strikes on Iran, a tanker on fire in the Strait of Hormuz, and retail traders somehow still buying leveraged chip ETFs. According to Interactive Brokers data flagged on CNBC, retail money flooded back into AI-exposed names within 48 hours of any dip — which is either impressive conviction or a concerning lack of self-preservation instinct.

The earnings picture is genuinely mixed. $GIS (General Mills) crushed expectations with $0.95 EPS vs. $0.80 consensus and a $3 billion savings plan through 2030 — the crowd loved it. $NKE (Nike) posted flat full-year revenue propped up by a one-time $986 million tariff windfall, with adjusted margins sitting at a soft 40.2% when you strip that out. $STZ (Constellation Brands) beat on EPS at $3.43 but watched wine and spirits crater 47% — a beer-saves-the-day story that Wall Street is tolerating for now.

Healthcare was Q2's quiet overachiever, gaining nearly 7% in June — its best month since November 2025 — and sentiment on CNBC suggests the smart money is rotating there while everyone argues about semiconductors. Retail is still chasing the AI trade, but the crowd paying attention is quietly building positions in pharma and industrials. The people who bought $META before the cloud announcement are currently insufferable at dinner parties — and honestly, fair enough.